StonvexLoading…
StonvexStonvexStonvexCore line items from CELU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $26.55M | $54.22M | $22.77M | $17.98M |
Operating Income | $-61.31M | $-38.36M | $-192.29M | $-25.60M |
Net Income | $-91.72M | $-57.89M | $-196.29M | $14.19M |
EPS (Diluted) | $-3.59 | $-2.64 | $-11.02 | $0.95 |
Total Assets | $107.33M | $132.68M | $143.89M | $401.07M |
Total Liabilities | $145.39M | $123.84M | $102.93M | $202.16M |
Cash & Equivalents | $6.17M | $738.00K | $227.00K | $13.97M |
Free Cash Flow OCF − CapEx | Not available | $-6.56M | $-39.73M | $-143.11M |
Shares Outstanding | 28.84M | 22.55M | 19.38M | 14.89M |